KCI Licensing, Inc. Company Profile

06:38 EDT 19th September 2018 | BioPortfolio

KCI’s innovative therapies make a difference in patients' lives every day. KCI’s therapies can be found helping patients recovering in all care settings. We design, manufacture, market and service a wide range of proprietary products that can improve clinical outcomes while helping to reduce the overall cost of patient care. Our products are backed by a worldwide network of service and clinical support.


Phone: 1-800-275-4524

News Articles [113 Associated News Articles listed on BioPortfolio]

What Is In-Licensing?

Licensing deals might be pharma’s preferred mode of business development these days—perhaps even more so than outright acquisitions. Read on to find out which pharmaceutical companies have been us...

Enzychem Lifesciences' Growth Continues in US, Adds Jeff Clark as New Chief Licensing Officer

By serving as Chief Licensing Officer, Dr. Clark will work on strengthening the worldwide Intellectual Property of the company and spearhead global licensing deals and Read more...

Zymeworks and Daiichi Sankyo Strike Second Licensing Agreement for Bispecific Antibody Platforms

Two years after entering into a licensing relationship Canada-based Zymeworks Inc. and Japanese pharma giant Daiichi Sankyo have entered into a second licensing agreement to expand immuno-oncology res...

Small-Cap Snapshot: Cara Therapeutics lands licensing deal, Revlon appoints its first female CEO

The biotech entered a licensing agreement with the largest provider of kidney dialysis in the US

Eiger expands lonafarnib licensing deal with Merck

Eiger BioPharmaceuticals has expanded a licensing agreement with Merck to cover the right to develop lonafarnib to treat Hutchinson-Gilford progeria...Read More... The post Eiger expands lonafarnib li...

Life cycle and regulatory evaluation of biosimilars

The life cycle of a biosimilar, like any biological, starts with research and development, then manufacturing, and is followed by regulatory evaluation of quality, safety and efficacy for both licensi...

Licensing Deals: Biohaven and AstraZeneca, Roivant and Patara, Gilead and Trianni

A number of companies are making the transition from the third quarter to the fourth quarter with licensing deals to bolster their pipelines. Here’s a look at just a few of them.

PAVmed finalizes licensing deal for Barrett's esophagus detection tech

A definitive licensing deal was completed by PAVmed for Case Western Reserve University's EsoCheck technology, a combination  -More- 

Drugs and Medications [0 Results]


PubMed Articles [40 Associated PubMed Articles listed on BioPortfolio]

Implementation Strategies Used by States to Support Physical Activity Licensing Standards for Toddlers in Early Care and Education Settings: An Exploratory Qualitative Study.

Child care settings have been a target for childhood obesity prevention efforts; changing licensing standards to require physical activity (PA)-related best practices is one strategy being used by sta...

Compliance with the U.S. Nuclear Regulatory Commission Revised Licensing Guidance for Radioactive Seed Localization.

The use of radioactive seed localization (RSL) as a reliable alternative to wire localization (WL) for guiding the surgical excision of non-palpable lesions has become more popular because of its demo...

'A true partner around the table?' Perceptions of how to strengthen public health's contributions to the alcohol licensing process.

There are increased opportunities for public health practitioners (PHPs) in England to shape alcohol availability and reduce harms through a statutory role in licensing processes in local government. ...

Examining Demographics, Prior Academic Performance, and United States Medical Licensing Examination Scores.

To examine whether demographic differences exist in United States Medical Licensing Examination (USMLE) examination scores and the extent to which any differences are explained by students' prior acad...

United States Medical Licensing Exam Step I Score as a Predictor of Neurosurgical Career Beyond Residency.

United States Medical Licensing Exam (USMLE) Step I score is cited as one of the most important factors when for applying to neurosurgery residencies. No studies have documented a correlation between ...

Clinical Trials [14 Associated Clinical Trials listed on BioPortfolio]

Annual Study for Fluarix Registration

A pre-requisite to the yearly licensing process of the Influenza vaccine (FluarixTM/ Influsplit SSW®) is to demonstrate in clinical studies, the immunogenicity and reactogenicity of the v...

Yearly Strain Variation Study, 2010/2011

The purpose of the study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to WHO/EU recommendation for the 2010/201...

A Post-Marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children

Following licensing of PoliorixTM in Korea, this study will collect safety data about the routine use of this vaccine in 600 children according to the regulations of Korean Food and Drugs ...

StaphVAX Immunogenicity in Orthopedic Implant Patients

S. aureus is the most common pathogen involved in prosthetic joint infection. StaphVAX® is a vaccine to prevent these infections, which conjugates the purified capsular polysaccharides of...

Yearly Strain Variation Study, 2009/2010

The purpose of this study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to World Heath Organization/European Uni...

Companies [448 Associated Companies listed on BioPortfolio]

ProPharma Partners (UK)

ProPharma Partners, Inc. assists biotechnology and pharmaceutical clients with corporate partnering, in-licensing, out-licensing, mergers or acquisitions, drug development, clinical planning, new vent...

Propharma Partners Incorporated USA

ProPharma Partners, Inc. assists biotechnology and pharmaceutical clients with corporate partnering, in-licensing, out-licensing, mergers or acquisitions, drug development, clinical planning, new vent...

AllianCat Tschannen - Pharma Research & Licensing Consultants

AllianCat delivers professional support to companies in the pharmaceutical, biotechnology and chemical arena by providing services for business development and licensing. The objective is to optimize ...

Innomedica Ltd

Innomedica Ltd. is an established international business development and licensing company focused on the Life Sciences. Innomedica provides professional services to biotechnology companies in three a...

New Renaissance Institute

New Renaissance Institute® (NRI, is a privately-held for-profit interdisciplinary R&D institution based in Belmont, California. NRI has innovat...

More Information about "KCI Licensing, Inc." on BioPortfolio

We have published hundreds of KCI Licensing, Inc. news stories on BioPortfolio along with dozens of KCI Licensing, Inc. Clinical Trials and PubMed Articles about KCI Licensing, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of KCI Licensing, Inc. Companies in our database. You can also find out about relevant KCI Licensing, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record